IGSF9B Inhibitors
IGSF9B inhibitors belong to a class of chemical compounds specifically designed to target and interfere with the activity of the IGSF9B gene or its encoded protein product. IGSF9B, or Immunoglobulin Superfamily Member 9B, is a protein belonging to the immunoglobulin superfamily, known for its role in cell-cell interactions, adhesion, and signaling. These inhibitors are developed to modulate the function of IGSF9B, which may be involved in various cellular processes related to cell adhesion, migration, and potentially other molecular interactions.
The primary mode of action for IGSF9B inhibitors typically involves their interaction with the IGSF9B protein or its associated molecules, disrupting its normal cellular functions. By inhibiting IGSF9B, these compounds may potentially affect cell adhesion, migration, and other cellular processes under its control. Researchers studying IGSF9B inhibitors aim to elucidate the specific roles of IGSF9B in various biological contexts, contributing to our understanding of its functions in cellular adhesion and signaling. These inhibitors serve as invaluable tools for advancing our knowledge of the complex molecular mechanisms governing cell-cell interactions and adhesion. In this context, they play a significant role in furthering our understanding of cell biology and molecular processes that are essential for normal tissue development and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid can influence gene expression by activating retinoic acid receptors, which may downregulate IGSF9B transcription in neuronal cells. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate acts by inhibiting dihydrofolate reductase, potentially affecting nucleotide synthesis and subsequent IGSF9B gene expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis in eukaryotic organisms, which could result in decreased IGSF9B expression by limiting protein translation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase, which could reduce the transcription of the IGSF9B gene. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin gallate has been shown to modulate gene expression, potentially influencing IGSF9B expression levels indirectly. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate acts as a histone deacetylase inhibitor, potentially altering the chromatin structure and decreasing IGSF9B expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to DNA and affects gene transcription, which could lead to reduced expression of IGSF9B. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is another histone deacetylase inhibitor that may modulate chromatin and lower IGSF9B gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Sirolimus inhibits the mTOR pathway, which is involved in protein synthesis and could affect IGSF9B expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine can alter DNA and RNA synthesis by intercalating into DNA, potentially reducing IGSF9B gene expression. | ||||||